From Sample to Insight: Technologies Driving the Future of Precision Oncology Assays
Discover how molecular diagnostics are transforming cancer detection, treatment, and monitoring.
Precision oncology is reshaping how cancer is diagnosed and treated, with molecular technologies at the center of this transformation. From early detection and tumor profiling to real-time treatment monitoring and recurrence tracking, these tools are guiding clinical decisions across the entire patient journey.
Discover What’s Next in Precision Oncology
From scalable qPCR mixes to ambient-stable NGS reagents, Meridian’s molecular and immunoassay technologies are advancing cancer diagnostics — driving progress from early detection to precision treatment.
Inside the eBook, you’ll learn:
- Molecular insights: How genomic profiling uncovers the mutations driving tumor progression—enabling more targeted therapies.
- Technology in action: The roles of qPCR, targeted NGS, and whole-genome sequencing in delivering accurate, scalable, and clinically relevant results.
- The future of oncology assays: Why workflow-optimized, scalable solutions are essential to expand access to precision medicine worldwide.